Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
Fiona P. Havers, Huong Pham, Christopher A. Taylor, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 10, pp. 1071-1071
Open Access | Times Cited: 149

Showing 26-50 of 149 citing articles:

Pediatric Vaccine Hesitancy in the United States—The Growing Problem and Strategies for Management Including Motivational Interviewing
Ashlesha Kaushik, Julia Fomicheva, Nathan Boonstra, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 115-115
Open Access
Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population
Geetesh Solanki, Susan Cleary, Francesca Little
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317686-e0317686
Open Access
Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus
Kristina L. Bajema, David Bui, Lei Yan, et al.
JAMA Internal Medicine (2025)
Closed Access
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients
Qian Wu, Hairuo Wu, Yabin Hu, et al.
Antiviral Research (2025), pp. 106092-106092
Closed Access
An updated review of pulmonary radiological features of acute and chronic pulmonary COVID-19
Raya Tcheroyan, Peter Makhoul, Scott Simpson
Current Opinion in Pulmonary Medicine (2025)
Closed Access
Prevalence and Risk Factors for Acute Kidney Injury in COVID-19-Hospitalized Patients in Poland Across Three Pandemic Periods
Paweł Edyko, Małgorzata Zdunek, Maja Nowicka, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1384-1384
Open Access
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial
Hiroshi Odaguchi, Sumiko Hyuga, Mariko Sekine, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 641-641
Open Access
Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–2021
Alissa O’Halloran, Michael Whitaker, Kadam Patel, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 14
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States
Megan Wallace, Hannah G. Rosenblum, Danielle Moulia, et al.
Vaccine (2023) Vol. 41, Iss. 44, pp. 6456-6467
Open Access | Times Cited: 12
Differences in the Evolution of Clinical, Biochemical, and Hematological Indicators in Hospitalized Patients with COVID-19 According to Their Vaccination Scheme: A Cohort Study in One of the World’s Highest Hospital Mortality Populations
Martha A. Mendoza-Hernandez, José Guzmán-Esquivel, Marco A. Ramos-Rojas, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 72-72
Open Access | Times Cited: 4
Mandatory COVID-19 vaccination for healthcare workers: A discussion paper
Della Maneze, Yenna Salamonson, Maxwell Grollman, et al.
International Journal of Nursing Studies (2022) Vol. 138, pp. 104389-104389
Open Access | Times Cited: 19
Reduction in COVID-19-related mortality over time but disparities across population subgroups
Mark W. Tenforde, Ruth Link‐Gelles
The Lancet Public Health (2023) Vol. 8, Iss. 5, pp. e327-e328
Open Access | Times Cited: 11
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study
Caige Huang, Yue Wei, Vincent Ka Chun Yan, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 6, pp. 403-413
Open Access | Times Cited: 11
Memory B cell development elicited by mRNA booster vaccinations in the elderly
Zijun Wang, Frauke Muecksch, Raphael Raspe, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 11
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108887-108887
Open Access | Times Cited: 3
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 3
Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review
Andreas Tofarides, Eirini Christaki, Haralampos Milionis, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2057-2057
Open Access | Times Cited: 17
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study
Ling Tong, Masoud Khani, Qiang Lü, et al.
Obesity Research & Clinical Practice (2022) Vol. 17, Iss. 1, pp. 47-57
Open Access | Times Cited: 17
Unveiling the Impact of COVID-19 Vaccines: A Meta-Analysis of Survival Rates Among Patients in the United States Based on Vaccination Status
Anderson E Ikeokwu, Rebecca Lawrence, Egbaoghene D Osieme, et al.
Cureus (2023)
Open Access | Times Cited: 9
Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study
Sihem Ben Fredj, Rim Ghammem, Nawel Zammit, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Considerations for de-escalating universal masking in healthcare centers
Caroline Landelle, Gabriel Birgand, James Price, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 8
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study
Ee Vien Low, Mohan Dass Pathmanathan, Suresh Kumar Chidambaram, et al.
International Journal of Infectious Diseases (2023) Vol. 135, pp. 77-83
Open Access | Times Cited: 8
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
Andrea Lombardi, Simone Villa, Marta Colaneri, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 3, pp. 467-473
Open Access | Times Cited: 2
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012246-e1012246
Open Access | Times Cited: 2
Synergistic evolution: the dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world
Yunhui Li, Xiaohan Zhang, Jingkun Yi, et al.
Journal of Infection (2024) Vol. 89, Iss. 6, pp. 106310-106310
Closed Access | Times Cited: 2

Scroll to top